前列腺癌根治性放疗后泌尿系事件与放疗前IPSS的关系
基于瑞典国家前列腺癌登记库2018–2023年4436例接受根治性放疗且诊断时记录IPSS的患者,按IPSS轻、中、重分层分析3年泌尿系事件累积发生率。结果显示放疗前IPSS越高,放疗后泌尿系事件风险越高,且该关联在前列腺体积、放疗类型及新辅助ADT各亚组中均存在。
要点
- 放疗前IPSS轻度者3年泌尿系事件发生率为19%,中度为28%,重度为39%。
- IPSS每增加5分,3年内发生泌尿系事件的风险增加20%。
- IPSS与泌尿系事件的关联在前列腺体积、放疗类型及新辅助ADT亚组中均可见。
核心结论
- 放疗前IPSS较高是根治性放疗后泌尿系事件风险增加的指标,总体及在前列腺体积、放疗类型和新辅助ADT亚组中均如此。
研究设计与样本
- 纳入瑞典国家前列腺癌登记库2018–2023年接受根治性放疗且诊断时登记IPSS的4436例前列腺癌患者。
- IPSS分层为轻度0–7分、中度8–19分、重度20–35分。
- 泌尿系事件定义为治疗后下尿路症状、感染及泌尿外科操作,基于ICD-10编码和患者登记库操作评估。
- 按IPSS、前列腺体积、放疗类型及新辅助ADT计算放疗后3年泌尿系事件的竞争风险累积发生比例。
主要发现
- 4436例中,43%为轻度、44%为中度、13%为重度放疗前IPSS。
- 放疗后3年泌尿系事件发生率:轻度IPSS为19%,中度IPSS为28%,重度IPSS为39%。
- IPSS与泌尿系事件的关联在前列腺体积、放疗类型及新辅助ADT各亚组中均观察到。
- IPSS每增加5分,3年内发生泌尿系事件的风险增加20%。
临床怎么用
- 放疗前应常规评估IPSS,用于识别放疗后泌尿系事件高风险患者。
- 对放疗前IPSS中度至重度患者,可加强放疗后泌尿系事件的监测与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the risk of urinary tract events after radical radiotherapy (RT) according to pre-RT (IPSS) overall and within subgroups of prostate volume, type of RT, and use of neoadjuvant androgen-deprivation therapy (ADT), as men who undergo RT for prostate cancer have a risk of urinary tract events. PATIENTS AND METHODS: Men in the National Prostate Cancer Register of Sweden who underwent RT between 2018 and 2023 for whom IPSS was registered at diagnosis were included. The IPSS was stratified as: low, 0-7; moderate, 8-19; and severe, 20-35 points. Urinary tract events were defined as lower urinary tract symptoms, infections, and urological procedures after treatment and assessed based on International Classification of Diseases and Related Health Problems, 10th Revision codes and procedures in The Patient Register. Competing risk of cumulative incidence proportion of urinary tract events at 3 year after RT was computed according to the IPSS, prostate volume, type of RT, and use of neoadjuvant ADT. RESULTS: Of the 4436 men included, 43% had mild, 44% moderate, and 13% severe pre-RT IPSS. Incidence of urinary tract events after RT was 19% at 3 years for men with mild IPSS, 28% for moderate IPSS, and 39% for severe IPSS. The association between IPSS and urinary tract events was observed within subgroups based on prostate volume, type of RT, and use of neoadjuvant ADT. A 5-unit increase in IPSS carried a 20% increased risk of having a urinary tract event within 3 years. CONCLUSION: A higher pre-RT IPSS is an indicator of increased risk of urinary tract events after RT - both overall and within subgroups of prostate volume, type of RT, and use of neoadjuvant ADT.
引用
- Zaurito P, Westerberg M, Garmo H, et al. Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score. BJU Int. 2025. PMID: 40937891. doi:10.1111/bju.16927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。